TickerFactsScreenerDevelopers

ZyVersa Therapeutics, Inc. (ZVSA) — Operating Income

Annual figures by fiscal year, from SEC filings.

2023: -$107.75M2024: -$9.14M2025: -$25.49M-$25.49M
2023Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$25.49M-179.0%
2024-$9.14M+91.5%
2023-$107.75M—